AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
HighCape Capital Acquisition
Acquired Company
Quantum-Si Incorporated
WashingtonBranfordBiotechnologyHealth CareBiotechnologyDescription
HighCape Capital Acquisition Corp. has completed its merger with Quantum-Si Incorporated. Quantum-Si specializes in semiconductor technologies for protein sequencing. After the merger, Quantum-Si is now publicly traded, while HighCape will cease to operate as an independent SPAC.
Fundz sees it the moment HighCape Capital Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Quantum-Si Incorporated?
Quantum-Si Incorporated was acquired by HighCape Capital Acquisition, based in Washington. The deal was reported on September 24, 2026. HighCape Capital Acquisition Corp. was a special purpose acquisition company (SPAC) formed to identify and complete a merger or acquisition in the healthcare or life sciences sectors. HighCape Capital Acquisition is privately held and operates in Biotechnology.
When did HighCape Capital Acquisition acquire Quantum-Si Incorporated?
HighCape Capital Acquisition's acquisition of Quantum-Si Incorporated was reported on September 24, 2026. HighCape Capital Acquisition Corp. has completed its merger with Quantum-Si Incorporated. Quantum-Si specializes in semiconductor technologies for protein sequencing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Quantum-Si Incorporated do?
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-gen It is publicly traded (QSI), operating in Biotechnology, and is based in Branford.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.